A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF

Name: A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF
Published: 2023
License: Public Domain

ViiV Healthcare · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

hiv hiv-infections

hiv, hiv infections, human immunodeficiency virus (hiv)-1, dolutegravir, lamivudine, bictegravir, emtricitabine, tenofovir alafenamide, dovato, biktarvy, switch study, ≥50 years

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 874737
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.